Add time:09/10/2019 Source:sciencedirect.com
The influence of alloxan diabetes, phenylbutazone (20 mg/kg), and D-penicillamine (30 mg/kg) on 6-SULFANILAMIDOINDAZOLE (cas 13744-68-8) arthritis was investigated. Arthritis was not altered by the alloxan-diabetic stage neither by injecting alloxan during developing arthritis nor by injecting it before the beginning of 6-sulfanilamidoindazole administration. However, the arthritis was completely suppressed by phenylbutazone after both methods of administration. D-penicillamine was without significant effect. Decrease of serum sulfhydryl groups and increase of serum diphenylamine value occurring during arthritis were prevented by phenylbutazone whereas alloxan and D-penicillamine did not.
We also recommend Trading Suppliers and Manufacturers of 6-SULFANILAMIDOINDAZOLE (cas 13744-68-8). Pls Click Website Link as below: cas 13744-68-8 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View